X4 Pharmaceuticals, Inc. buy HC Wainwright
Start price
22.03.24
/
50%
€1.35
Target price
22.03.25
€2.78
Performance (%)
-59.11%
Price
02.10.24
€0.55
Summary
This prediction is currently active. Massive losses of -59.11% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 22.03.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | -13.139% | -13.139% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by HC_Wainwright for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat
Stopped prediction by HC_Wainwright for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.60
28.06.24
28.06.24
€4.67
28.06.25
28.06.25
-8.15%
02.10.24
02.10.24
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€1.04
30.04.24
30.04.24
€4.67
30.04.25
30.04.25
-46.67%
02.10.24
02.10.24
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.95
11.08.23
11.08.23
€2.73
11.08.24
11.08.24
-40.11%
12.08.24
12.08.24